Alcon Sustainability Profile
Alcon, officially known as Alcon Inc., is a global leader in eye care, headquartered in Switzerland (CH). Founded in 1945, the company has established a strong presence in major operational regions, including North America, Europe, and Asia. Alcon is renowned for its innovative products in the ophthalmic industry, focusing on surgical and vision care solutions. The company’s core offerings include advanced surgical equipment, contact lenses, and eye care products, distinguished by their cutting-edge technology and commitment to improving patient outcomes. Alcon's dedication to research and development has positioned it as a market leader, with notable achievements in enhancing vision correction and surgical precision. With a rich history and a focus on innovation, Alcon continues to shape the future of eye care globally.
DitchCarbon Score
How does Alcon's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Alcon's score of 49 is higher than 69% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Alcon's reported carbon emissions
In 2024, Alcon, headquartered in Switzerland (CH), reported total carbon emissions of approximately 74,202,000 kg CO2e for Scope 1 and about 130,776,000 kg CO2e for Scope 2 (market-based). This brings their combined Scope 1 and 2 emissions to around 204,978,000 kg CO2e. In comparison, in 2023, Alcon's emissions were approximately 75,183,000 kg CO2e for Scope 1 and about 158,299,000 kg CO2e for Scope 2, totalling around 233,482,000 kg CO2e. Alcon has set a significant climate commitment to achieve carbon neutrality across its global operations for Scope 1 and Scope 2 emissions by 2030. This initiative reflects their dedication to reducing their carbon footprint and aligns with industry standards for climate action. The emissions data is sourced directly from Alcon Inc., with no cascaded data from a parent or related organization. Alcon's ongoing efforts and targets demonstrate a proactive approach to addressing climate change and enhancing sustainability within the healthcare sector.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | - | - | - | - | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | - | - | - | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | - | 0,000,000,000 | - | - | - | - | - |
How Carbon Intensive is Alcon's Industry?
How Carbon Intensive is Alcon's Location?
Alcon's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Alcon has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
